GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,577,000 | +128.7% | 272,788 | +7.3% | 0.01% | +150.0% |
| Q2 2022 | $8,122,000 | -14.0% | 254,194 | -6.8% | 0.00% | 0.0% |
| Q1 2022 | $9,443,000 | +18.7% | 272,603 | +0.3% | 0.00% | +100.0% |
| Q4 2021 | $7,954,000 | +14.7% | 271,727 | -0.1% | 0.00% | 0.0% |
| Q3 2021 | $6,932,000 | -25.4% | 272,051 | +2.5% | 0.00% | -50.0% |
| Q2 2021 | $9,298,000 | +2.4% | 265,503 | +19.1% | 0.00% | 0.0% |
| Q1 2021 | $9,081,000 | -8.6% | 222,841 | -2.8% | 0.00% | 0.0% |
| Q4 2020 | $9,932,000 | -25.5% | 229,321 | -5.1% | 0.00% | -33.3% |
| Q3 2020 | $13,329,000 | -9.3% | 241,743 | +3.8% | 0.00% | -25.0% |
| Q2 2020 | $14,697,000 | +1.9% | 232,786 | -17.5% | 0.00% | -20.0% |
| Q1 2020 | $14,420,000 | -40.4% | 282,247 | -7.3% | 0.01% | -16.7% |
| Q4 2019 | $24,190,000 | -6.7% | 304,317 | -43.1% | 0.01% | -14.3% |
| Q3 2019 | $25,932,000 | -7.4% | 534,462 | +0.4% | 0.01% | -12.5% |
| Q2 2019 | $28,009,000 | -9.8% | 532,468 | -9.2% | 0.01% | -11.1% |
| Q1 2019 | $31,047,000 | +44.3% | 586,572 | +11.9% | 0.01% | +28.6% |
| Q4 2018 | $21,513,000 | +140.3% | 524,071 | +122.5% | 0.01% | +250.0% |
| Q3 2018 | $8,951,000 | -16.3% | 235,541 | -0.4% | 0.00% | -33.3% |
| Q2 2018 | $10,689,000 | +0.0% | 236,471 | +6.9% | 0.00% | 0.0% |
| Q1 2018 | $10,686,000 | +37.0% | 221,260 | +11.6% | 0.00% | +50.0% |
| Q4 2017 | $7,799,000 | +33.0% | 198,201 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $5,865,000 | +16.4% | 188,882 | +2.6% | 0.00% | +100.0% |
| Q2 2017 | $5,037,000 | -1.9% | 184,173 | +32.1% | 0.00% | 0.0% |
| Q1 2017 | $5,137,000 | +357.0% | 139,389 | +79.2% | 0.00% | – |
| Q4 2016 | $1,124,000 | -31.5% | 77,796 | +9.1% | 0.00% | – |
| Q3 2016 | $1,642,000 | +130.6% | 71,275 | +66.1% | 0.00% | – |
| Q2 2016 | $712,000 | +49.9% | 42,900 | +43.2% | 0.00% | – |
| Q1 2016 | $475,000 | -51.0% | 29,960 | +0.0% | 0.00% | – |
| Q4 2015 | $969,000 | +41.9% | 29,955 | +85.1% | 0.00% | – |
| Q3 2015 | $683,000 | – | 16,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |